Healthcare provider profile · identity verified

Akash D Patel, MD

Family Practice · EAST BRIDGEWATER, MA · NPI 1609032580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	556	193
Lisinopril	Lisinopril	481	138
Rosuvastatin Calcium	Rosuvastatin Calcium	390	131
Metoprolol Succinate	Metoprolol Succinate	373	130
Amlodipine Besylate	Amlodipine Besylate	372	127
Losartan Potassium	Losartan Potassium	360	123
Omeprazole	Omeprazole	356	115
Levothyroxine Sodium	Levothyroxine Sodium	301	100
Furosemide	Furosemide	212	59
Simvastatin	Simvastatin	203	66
Metformin Hcl	Metformin Hcl	185	61
Hydrochlorothiazide	Hydrochlorothiazide	169	59
Gabapentin	Gabapentin	137	41
Prednisone	Prednisone	131	115
Trazodone Hcl	Trazodone Hcl	131	55
Tamsulosin Hcl	Tamsulosin Hcl	129	45
Albuterol Sulfate Hfa	Albuterol Sulfate	124	57
Fluoxetine Hcl	Fluoxetine Hcl	121	41
Allopurinol	Allopurinol	120	42
Atenolol	Atenolol	113	36
Lorazepam	Lorazepam	100	29
Eliquis	Apixaban	97	34
Metoprolol Tartrate	Metoprolol Tartrate	94	28
Fluticasone Propionate	Fluticasone Propionate	86	53
Pantoprazole Sodium	Pantoprazole Sodium	84	33
Azithromycin	Azithromycin	82	75
Ozempic	Semaglutide	79	15
Pravastatin Sodium	Pravastatin Sodium	78	24
Duloxetine Hcl	Duloxetine Hcl	74	21
Trulicity	Dulaglutide	74	15
Escitalopram Oxalate	Escitalopram Oxalate	71	23
Metformin Hcl Er	Metformin Hcl	71	25
Valsartan	Valsartan	70	22
Famotidine	Famotidine	68	27
Jardiance	Empagliflozin	65	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	37
Citalopram Hbr	Citalopram Hydrobromide	61	18
Bupropion Hcl Sr	Bupropion Hcl	60	12
Xarelto	Rivaroxaban	59	14
Carvedilol	Carvedilol	58	15
Nabumetone	Nabumetone	57	55
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	56	49
Finasteride	Finasteride	53	21
Ezetimibe	Ezetimibe	47	21
Mounjaro	Tirzepatide	47	13
Alprazolam	Alprazolam	45	17
Glipizide	Glipizide	45	16
Sertraline Hcl	Sertraline Hcl	45	17
Fenofibrate	Fenofibrate,micronized	44	12
Warfarin Sodium	Warfarin Sodium	44	12
Clopidogrel	Clopidogrel Bisulfate	43	18
Spironolactone	Spironolactone	43	15
Doxycycline Monohydrate	Doxycycline Monohydrate	42	39
Bupropion Xl	Bupropion Hcl	41	14
Potassium Chloride	Potassium Chloride	41	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	39	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	37
Glimepiride	Glimepiride	37	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Lovastatin	Lovastatin	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Januvia	Sitagliptin Phosphate	33	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Ibuprofen	Ibuprofen	32	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	11
Ondansetron Hcl	Ondansetron Hcl	29	22
Triamcinolone Acetonide	Triamcinolone Acetonide	29	26
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Cephalexin	Cephalexin	28	26
Entresto	Sacubitril/Valsartan	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	25
Alendronate Sodium	Alendronate Sodium	24	11
Glipizide Er	Glipizide	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	12
Ofloxacin	Ofloxacin	22	20
Nystatin	Nystatin	21	15
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Colchicine	Colchicine	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Tramadol Hcl	Tramadol Hcl	18	13
Celecoxib	Celecoxib	17	suppressed
Naproxen	Naproxen	17	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	12
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Amoxicillin	Amoxicillin	15	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	15	suppressed
Primidone	Primidone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Unifine Pentips	Pen Needle, Diabetic	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	14
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Baclofen	Baclofen	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error